The following is a summary of “Efficacy and safety of gefapixant in women with chronic cough and cough-induced stress urinary ...

The company is advancing multiple trials, including a human abuse potential trial, a Phase IIb study for chronic cough in idiopathic pulmonary fibrosis (IPF), and a Phase IIa trial for refractory ...

Trevi Therapeutics ( (TRVI) ) has released its Q3 earnings. Here is a breakdown of the information Trevi Therapeutics presented to its ...

Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy ...

TCGFB, a private biotech founded by healthcare VC The Column Group, is tapping California biotech Surrozen to discover ...

The health expert has also issued advice on when you should see your GP if you have a cough that won't go away ...

A cough is a common symptom that can be caused by a number of illnesses and conditions - but in some instances you might need ...

The toxin strychnine, the primary component of the traditional Chinese medicine, may act in the STAT3 pathway, investigators ...

Idiopathic hypersomnia (IH ... With that said, Trotti says about 20% of people with hypersomnia also have chronic fatigue syndrome. But a careful history of your symptoms can help your doctor ...

Idiopathic hypersomnia (IH) is, in many ways, a mystery. Its cause is unknown. Only one FDA-approved treatment exists. Even diagnosing this disorder, which brings excessive sleepiness in the ...

for the treatment of chronic cough in idiopathic pulmonary fibrosis (IPF) and refractory chronic cough (RCC), today announced that it has completed enrollment in its Phase 2a trial for the ...